Clinical practice guidelines for COVID-19COVID-19Clinical practice guidelinesPublic health emergenciesdoi:10.1016/j.imr.2020.100487Yaolong ChenXuan YuIntegrative Medicine Research
We used the STROBE guidelines during the preparation of this report (Vandenbroucke et al., 2007). 2.1. Design & setting We applied a cross-sectional survey study design to examine nursing students' experiences during clinical placement in the midst of the COVID-19 pandemic in nine Belgian ...
●(See "COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis".) To continue reading this article, you must sign in with your personal, hospital, or group practice subscription. Subscribe Sign in Disclaimer: This generalized information is ...
Our patients represented those encountered in daily clinical practice better than those enrolled in clinical trials. Our study also has a few limitations. First, patients with COVID-19 who used oral antivirals had more comorbidities and past hospitalization. We compensated for this discrepancy by PS...
This study aimed to systematically investigate the consistency of recommendations from the available clinical practice guidelines (CPGs) to those of the WHO on the management of critically ill COVID-19 patients. Methods We examined CPGs and UpToDate point-of-care resources on the management of ...
covid-19 patients. hfsa, acc, and aha recommend continuing the use of such agents for patients as currently prescribed, and advised against adding or removing any raas-related treatments beyond actions based on standard clinical practice. covid-19 and statins in 2014, statins were includ...
The viral epidemic caused by the new Coronavirus SARS-CoV-2 is responsible for the new Coronavirus disease-2019 (Covid-19). Fifteen percent of the Covid-19 patients will require hospital stay, and 10% of them will need urgent respiratory and hemodynamic support in the intensive care unit (...
Despite the availability of effective treatments for asthma the real life asthma control is lower than expected. The aim of this study was to evaluate the barriers in achieving asthma control in clinical practice during the COVID-19 pandemic according to the literature data. There are both ...
Here we report a synthesis on COVID-19 literature. We focused on data that was needed daily in clinical practice to improve patients’ care and the management of this epidemic. 1. Viral origin, genetic and phylogeny This novel illness was rapidly associated with a previously unknown virus, tem...
And thirdly, what should happen to ongoing and future trials of other COVID-19 vaccine candidates currently in clinical development. Investigators, regulators, and bioethicists have provided the scientific, regulatory, and ethical basis for guiding this discussion;3, 4, 5, 6, 7, 8, 9 some ...